TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25792607

Group type: EXPERIMENTAL
Intervention: Mass isoniazid preventive therapy for 9 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Optimized intervention (increased implementation characteristics)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Additional interventions (improving diagnostics, reducing treatment delay, providing continuous isoniazid preventive therapy to HIV-positive people, scaling up antiretroviral treatment coverage)
Number of subjects: 0
Study: 24370263

Group type: EXPERIMENTAL
Intervention: Personalised, home-based nutritional counselling by trained Community Health Workers on maternal, infant and young child nutrition (MIYCN)
Number of subjects: 780

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned in the abstract)
Number of subjects: 780
Study: 21692770

Group type: EXPERIMENTAL
Intervention: Nurse Practitioners (NPs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dermatologists
Number of subjects: 0
Study: 18165596

Group type: EXPERIMENTAL
Intervention: IV patient-controlled morphine
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: IV patient-controlled pethidine
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: IV patient-controlled tramadol
Number of subjects: 126
Study: 16446021

Group type: EXPERIMENTAL
Intervention: Mild memory impairment group (n = 30)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Normal elderly group (n = 77)
Number of subjects: 107
Study: 12590006

Group type: EXPERIMENTAL
Intervention: Oral alendronate (10 mg/day, n=18)
Number of subjects: 39

Group type: COMPARATOR
Intervention: IV pamidronate (n=21)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 39
Study: 11794823

Group type: EXPERIMENTAL
Intervention: Continuous combined hormone replacement therapy (0.625 mg conjugated estrogen/day combined with medroxyprogesterone 5 mg/day)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Pravastatin 20 mg/day
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Continuous combined hormone replacement therapy plus pravastatin
Number of subjects: 35
Study: 9740079

Group type: EXPERIMENTAL
Intervention: Anastrozole 1 mg once daily
Number of subjects: 764

Group type: EXPERIMENTAL
Intervention: Anastrozole 10 mg once daily
Number of subjects: 764

Group type: COMPARATOR
Intervention: Megestrol acetate 40 mg 4 times daily
Number of subjects: 764
Study: 7992252

Group type: EXPERIMENTAL
Intervention: Patients with ET and PV
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Patients with ET and PV with previous thrombotic episodes
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Younger patients with ET and PV
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Patients with PV
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Patients with ET
Number of subjects: 33
Study: 2659442

Group type: EXPERIMENTAL
Intervention: Single dose of 3 g amoxicillin (group A)
Number of subjects: 91

Group type: COMPARATOR
Intervention: 4-day course of 3 X 750 mg amoxicillin (group B)
Number of subjects: 91
Study: 4613531

Group type: EXPERIMENTAL
Intervention: Prostaglandin F2alpha (PGF2alpha) administered extraamniotically
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Prostaglandin F2alpha (PGF2alpha) administered intraamniotically
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Histopathological studies on gestational sacs (group 1: PGF2alpha extraamniotic, group 2: PGF2alpha intraamniotic, group 3: hysterotomy)
Number of subjects: 124
Study: 30911991

Group type: EXPERIMENTAL
Intervention: Bacillus coagulans Unique IS2 (2 billion CFU)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 100
Study: 30594403

Group type: EXPERIMENTAL
Intervention: Bacterial cellulose graft
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Fat graft
Number of subjects: 120

Group type: COMPARATOR
Intervention: Temporalis fascia graft
Number of subjects: 120
Study: 30464914

Group type: EXPERIMENTAL
Intervention: i/v ceftazidine 1 gm bd with oral ciprofloxacin 750 mg bd
Number of subjects: 20

Group type: COMPARATOR
Intervention: surgical debridement with oral ciprofloxacin 750 mg bd
Number of subjects: 20
Study: 26466613

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 20 mg od (or 15 mg od in patients with moderate renal insufficiency)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Warfarin (INR target 2.5)
Number of subjects: 0
Study: 24433817

Group type: EXPERIMENTAL
Intervention: Manga comic
Number of subjects: 57

Group type: COMPARATOR
Intervention: Non-health-related newsletter
Number of subjects: 57
Study: 22229757

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Eye Movement Desensitization and Reprocessing (EMDR)
Number of subjects: 62
Study: 19106240

Group type: EXPERIMENTAL
Intervention: Low-salt diet (LS; 50 mmol Na/d)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Usual-salt diet (US; 150 mmol Na/d)
Number of subjects: 29
Study: 17145785

Group type: EXPERIMENTAL
Intervention: Crushed voriconazole tablets
Number of subjects: 20

Group type: COMPARATOR
Intervention: Whole voriconazole tablets
Number of subjects: 20
Study: 15000672

Group type: EXPERIMENTAL
Intervention: Training group (n = 32) participated in a 12-week, 3 days per week, exercise and health education program
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (n = 21)
Number of subjects: 53
Study: 11993619

Group type: EXPERIMENTAL
Intervention: High rate of fluid intake (H) - 120% of BW loss ingested as 60%, 40%, and 20% in the 1st, 2nd, and 3rd hours of recovery, respectively.
Number of subjects: 8

Group type: COMPARATOR
Intervention: Low rate of fluid intake (L) - 120% of BW loss ingested at 24% x h(‐1) during 5 hours.
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High rate of fluid intake (H)
Number of subjects: 8
Study: 10546017

Group type: COMPARATOR
Intervention: Sera from diabetic patients (type 1 and type 2) applied to N1E‐115 neuroblastoma cells
Number of subjects: 39

Group type: COMPARATOR
Intervention: Sera from diabetic patients (type 1 and type 2) applied to VSC4.1 neuroblastoma cells
Number of subjects: 39

Group type: COMPARATOR
Intervention: Sera from patients with motor neuropathy
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Sera from type 1 diabetic patients
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Sera from type 2 diabetic patients
Number of subjects: 39
Study: 7795155

Group type: EXPERIMENTAL
Intervention: 20 mg/day beta‐carotene for 14 weeks
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149

Group type: COMPARATOR
Intervention: Comparison with non-smokers (n = 54)
Number of subjects: 149
Study: 1693411

Group type: EXPERIMENTAL
Intervention: Amoxicillin combined with xylometazoline hydrochloride nose drops
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Maxillary sinus drainage
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Combination of maxillary sinus drainage and amoxicillin with xylometazoline
Number of subjects: 141
Study: 388714

Group type: EXPERIMENTAL
Intervention: Theophylline-7-acetic acid (T7AA)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 30189465

Group type: EXPERIMENTAL
Intervention: Nasal masks
Number of subjects: 85

Group type: COMPARATOR
Intervention: Oronasal masks
Number of subjects: 85

Group type: COMPARATOR
Intervention: Nasal pillows
Number of subjects: 85

Group type: COMPARATOR
Intervention: Oronasal masks (best adherence subgroup)
Number of subjects: 85
Study: 28234636

Group type: EXPERIMENTAL
Intervention: Femoral catheter plus sciatic nerve blocks
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Ropivacaine-based periarticular injection
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine-based periarticular injection
Number of subjects: 165
Study: 25275888

Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg·kg(‐1))
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 23841901

Group type: EXPERIMENTAL
Intervention: Alexander Technique lessons (20 sessions of 30 minutes each)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Acupuncture (12 sessions of 50 minutes each)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 500
Study: 22001096

Group type: EXPERIMENTAL
Intervention: Mimic dVTrainer (MdVT)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: da Vinci Surgical System (dVSS)
Number of subjects: 16

Group type: COMPARATOR
Intervention: No additional training (Control Group 3)
Number of subjects: 16
Study: 19369530

Group type: EXPERIMENTAL
Intervention: Probiotic mixture containing bifidobacteria and lactobacilli
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17530106

Group type: EXPERIMENTAL
Intervention: Urea breath test (UBT)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Questionnaire on upper gastrointestinal (UGI) symptoms
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Comparison between preclinical and clinical group of students
Number of subjects: 120
Study: 15339328

Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg/q.d.s.
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Pantoprazole 20 mg/q.d.s.
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Pantoprazole 10 mg/q.d.s.
Number of subjects: 349

Group type: COMPARATOR
Intervention: Ranitidine 150 mg/b.d.
Number of subjects: 349
Study: 11603627

Group type: EXPERIMENTAL
Intervention: 8 MIU IFN‐β
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 12 MIU IFN‐β
Number of subjects: 0
Study: 9647334

Group type: EXPERIMENTAL
Intervention: Troglitazone
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 9748034

Group type: EXPERIMENTAL
Intervention: Selegiline
Number of subjects: 589

Group type: COMPARATOR
Intervention: Non-selegiline (Control)
Number of subjects: 589

Group type: EXPERIMENTAL
Intervention: Levodopa plus Selegiline
Number of subjects: 589

Group type: COMPARATOR
Intervention: Levodopa (Control)
Number of subjects: 589

Group type: COMPARATOR
Intervention: Selegiline vs Non-selegiline
Number of subjects: 589

Group type: COMPARATOR
Intervention: Selegiline/Levodopa vs Levodopa
Number of subjects: 589
Study: 1825037

Group type: EXPERIMENTAL
Intervention: Intracoronary administration of acetylcholine or ergonovine
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Left coronary spasm
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Right coronary spasm
Number of subjects: 19

Group type: COMPARATOR
Intervention: Nonprovoked cases
Number of subjects: 19
Study: 6602993

Group type: EXPERIMENTAL
Intervention: Positional feedback stimulation training and cyclical electrical stimulation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Physical therapy (Control)
Number of subjects: 40
Study: 31775837

Group type: EXPERIMENTAL
Intervention: Bolus therapy with 20-40 ml/kg 5% albumin or 0.9% saline over 1-2 h
Number of subjects: 3138

Group type: COMPARATOR
Intervention: No bolus (control, 4 ml/kg/hour maintenance)
Number of subjects: 3138

Group type: EXPERIMENTAL
Intervention: Bolus therapy
Number of subjects: 3138
Study: 29985860

Group type: EXPERIMENTAL
Intervention: Telenursing intervention with weekly follow-up phone calls for 12 weeks and availability of telenurse for calls anytime.
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group with one follow-up phone call after 12 weeks.
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Telenursing program for caregivers.
Number of subjects: 72
Study: 26818893

Group type: EXPERIMENTAL
Intervention: Insulin initiation willingness
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Socioeconomic status and insulin appraisals
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Regression model
Number of subjects: 261
Study: 24996223

Group type: EXPERIMENTAL
Intervention: Resistance training (Arm A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Passive physical therapy (Arm B)
Number of subjects: 60
Study: 23342560

Group type: EXPERIMENTAL
Intervention: Probiotic supplemented milk containing Lactobacillus rhamnosus hct 70
Number of subjects: 40

Group type: COMPARATOR
Intervention: Plain milk (Control)
Number of subjects: 40
Study: 20518930

Group type: EXPERIMENTAL
Intervention: Gutta‐flow
Number of subjects: 38

Group type: COMPARATOR
Intervention: AH‐Plus
Number of subjects: 38
Study: 19190878

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG) 1g/kg for two consecutive days (total dose 2 g/kg)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Intravenous anti-D immunoglobulin 75 microg/kg (single dose)
Number of subjects: 81
Study: 16187243

Group type: EXPERIMENTAL
Intervention: Pamidronate (treatment)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 11
Study: 14508352

Group type: EXPERIMENTAL
Intervention: CsA-ME with C2 monitoring
Number of subjects: 296
Study: 10378713

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 73

Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 73
Study: 9133170

Group type: EXPERIMENTAL
Intervention: Intraoperative autotransfusion (MAT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Homologous transfusion
Number of subjects: 24
Study: 8229498

Group type: EXPERIMENTAL
Intervention: Cefixime (8 mg/kg per day for 5 days)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMX, 10-50 mg/kg per day for 5 days)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Cefixime
Number of subjects: 77

Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMX)
Number of subjects: 77
Study: 3492030

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Active stimulation
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo apparatus
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 31199595

Group type: EXPERIMENTAL
Intervention: Reconval K1 cream
Number of subjects: 0

Group type: COMPARATOR
Intervention: Doxycycline
Number of subjects: 0
Study: 29526857

Group type: EXPERIMENTAL
Intervention: Cathodal transcranial direct current stimulation over the contralesional cerebellar hemisphere + cathodal transcutaneous spinal direct current stimulation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Anodal transcranial direct current stimulation over the damaged cerebral hemisphere + cathodal transcutaneous spinal direct current stimulation
Number of subjects: 20
Study: 26994228

Group type: EXPERIMENTAL
Intervention: GDHT (goal-directed haemodynamic treatment)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Routine fluid treatment (clinician-guided)
Number of subjects: 142
Study: 24217219

Group type: EXPERIMENTAL
Intervention: Cortisol infusion to increase plasma cortisol concentration to a level associated with major physiologic stress.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline pre-treatment (Control group).
Number of subjects: 0
Study: 22440088

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Untreated blood pressure
Number of subjects: 2
Study: 19567826

Group type: EXPERIMENTAL
Intervention: Nicotine patch (21 mg/24 hr)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 400
Study: 17167258

Group type: EXPERIMENTAL
Intervention: Probing with a sharp dental probe (No. 23) on occlusal surfaces with initial carious lesions.
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Probing with a sharp dental probe (No. 23) on sound occlusal surfaces.
Number of subjects: 18

Group type: COMPARATOR
Intervention: Unprobed occlusal surfaces (negative controls).
Number of subjects: 18
Study: 15637449

Group type: EXPERIMENTAL
Intervention: Female patients
Number of subjects: 17370

Group type: COMPARATOR
Intervention: Male patients
Number of subjects: 17370
Study: 12359986

Group type: COMPARATOR
Intervention: Dietary intervention program administered by a dietitian
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Dietary intervention program administered by a doctor of chiropractic in conjunction with chiropractic spinal manipulation
Number of subjects: 140
Study: 7954561

Group type: EXPERIMENTAL
Intervention: Nitrendipine
Number of subjects: 86

Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Nitrendipine and Captopril
Number of subjects: 86
Study: 2900483

Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clobazam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29255109

Group type: EXPERIMENTAL
Intervention: PsyScan e-tool intervention
Number of subjects: 336

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 336
Study: 28784536

Group type: EXPERIMENTAL
Intervention: Matcha tea
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Matcha tea bar (4 g matcha tea powder)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo tea
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo bar
Number of subjects: 23
Study: 26742400

Group type: EXPERIMENTAL
Intervention: Posterior TAP block
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Lateral TAP block
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 29
Study: 23565969

Group type: EXPERIMENTAL
Intervention: A + PAAC (Physical Activity Across the Curriculum)
Number of subjects: 687

Group type: COMPARATOR
Intervention: Control
Number of subjects: 687
Study: 21494061

Group type: EXPERIMENTAL
Intervention: Wisdom psychotherapy (PTED-specific cognitive behaviour therapy)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Wisdom and hedonia psychotherapy
Number of subjects: 82

Group type: COMPARATOR
Intervention: Routine multidimensional cognitive behaviour therapy
Number of subjects: 82
Study: 19268068

Group type: EXPERIMENTAL
Intervention: Hypertensive patients with different left ventricular geometric patterns (concentric hypertrophy, eccentric hypertrophy, concentric remodeling, normal)
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Hypertensive patients with different left ventricular geometric patterns
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Presence of diabetes at study entry
Number of subjects: 265
Study: 16794200

Group type: EXPERIMENTAL
Intervention: Dispersible aspirin 75 mg
Number of subjects: 71

Group type: COMPARATOR
Intervention: Enteric-coated 75 mg aspirin
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Asasantin (25-mg standard release aspirin plus 200-mg modified-release dipyridamole given twice daily)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Other aspirin preparations (3 different enteric-coated 75 mg aspirins)
Number of subjects: 71
Study: 15185208

Group type: EXPERIMENTAL
Intervention: Insulin infusion
Number of subjects: 4

Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 4
Study: 10657421

Group type: EXPERIMENTAL
Intervention: Combined clinical and imaging variables
Number of subjects: 256

Group type: COMPARATOR
Intervention: Clinical variables alone
Number of subjects: 256

Group type: COMPARATOR
Intervention: Imaging variables alone
Number of subjects: 256
Study: 9310008

Group type: EXPERIMENTAL
Intervention: Esophageal manometry during polysomnography
Number of subjects: 155

Group type: COMPARATOR
Intervention: Matched control group without esophageal catheters
Number of subjects: 155
Study: 8220802

Group type: EXPERIMENTAL
Intervention: Tannic acid
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Central vacuum cleaners
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: HEPA vacuum cleaners
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Micro-filter vacuum cleaners
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 3295148

Group type: EXPERIMENTAL
Intervention: Computer-assisted dosing (Warfcalc)
Number of subjects: 75
Study: 31664515

Group type: EXPERIMENTAL
Intervention: hemithyroidectomy with prophylactic ipsilateral central neck dissection (pCND)
Number of subjects: 164

Group type: COMPARATOR
Intervention: hemithyroidectomy without prophylactic ipsilateral central neck dissection (pCND)
Number of subjects: 164
Study: 29736742

Group type: EXPERIMENTAL
Intervention: Plant Balm (PB) applied 2-3 times/day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Petroleum Control (PC)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Plant Balm (PB)
Number of subjects: 60
Study: 28504313

Group type: EXPERIMENTAL
Intervention: Optical see-through head-mounted display (OST-HMD)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Normal ultrasound monitor
Number of subjects: 2
Study: 26714284

Group type: EXPERIMENTAL
Intervention: MIG-HD trial (intervention group)
Number of subjects: 93

Group type: COMPARATOR
Intervention: RIL-HD trial (placebo control group)
Number of subjects: 93
Study: 22780449

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 23
Study: 21490036

Group type: EXPERIMENTAL
Intervention: CRT 'on' (day 0)
Number of subjects: 16

Group type: COMPARATOR
Intervention: CRT 'off' (day 14)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: CRT re‐initiation (day 14)
Number of subjects: 16

Group type: COMPARATOR
Intervention: CRT cessation
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: CRT re‐initiation
Number of subjects: 16
Study: 18986746

Group type: EXPERIMENTAL
Intervention: Peer educator, network-oriented intervention
Number of subjects: 983

Group type: COMPARATOR
Intervention: Life-skills intervention
Number of subjects: 983

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 983
Study: 17298754

Group type: EXPERIMENTAL
Intervention: External plus intracavitary irradiation (58-62 Gy external + 15-20 Gy intracavitary)
Number of subjects: 321

Group type: COMPARATOR
Intervention: Conventional irradiation (66-74 Gy)
Number of subjects: 321
Study: 15544714

Group type: EXPERIMENTAL
Intervention: Moderate altitude (1,700 m) vacation
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Low altitude (300 m) vacation
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Follow-up after vacation
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Active individuals
Number of subjects: 72
Study: 11502903

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 300 mg twice daily
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Remacemide hydrochloride 200 mg three times daily
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Both coenzyme Q10 and remacemide
Number of subjects: 347

Group type: COMPARATOR
Intervention: Placebo (neither treatment)
Number of subjects: 347